Effect of protease-activated receptor-2 deficiency on allergic dermatitis in the mouse ear

被引:76
作者
Kawagoe, J
Takizawa, T
Matsumoto, J
Tamiya, M
Meek, SE
Smith, AJH
Hunter, GD
Plevin, R
Saito, N
Kanke, T
Fujii, M
Wada, Y
机构
[1] Kowa Co Ltd, Div Pharmaceut, Tokyo Res Labs, Tokyo 1890022, Japan
[2] Univ Edinburgh, Ctr Genome Res, Edinburgh EH9 3JQ, Midlothian, Scotland
[3] Univ Strathclyde, Strathclyde Inst Biomed Sci, Dept Physiol & Pharmacol, Glasgow G4 0NR, Lanark, Scotland
关键词
protease-activated receptor-2; knockout mice; allergic dermatitis; contact hypersensitivity; passive cutaneous anaphylaxis;
D O I
10.1254/jjp.88.77
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
To investigate the involvement of protease-activated receptor-2 (PAR-2) in allergic dermatitis, we generated PAR-2-deficient (PAR-2(-/-)) mice. Ear thickness, contact hypersensitivity (CH) induced by topical application of picryl chloride (PC) or oxazolone (Ox) after sensitization, and vascular permeability after ear passive cutaneous anaphylaxis (PCA) were compared between wild-type (WT) and PAR-2(-/-) mice. Ear thickness was almost the same in untreated WT and PAR-2(-/-) mice. Topical application of PC or Ox thickened the ears at 6, 24 and 48 h after challenge with a peak at 24 h in WT mice. In PAR-2(-/-) mice, the ear swelling induced by both PC and Ox was suppressed at every time point, and significant inhibition was found at 24 h in PC-induced CH and at 24 and 48 h in Ox-induced CH. Histopathological observation of the ears at 24 h after challenge revealed that PC- or Ox-induced ear edema and infiltration of inflammatory cells in WT mice were greatly attenuated in PAR-2(-/-) mice. The vascular permeability in the ears after PCA was not different between WT and PAR-2(-/-) mice. These results strongly suggest that PAR-2 plays a crucial role in type IV allergic dermatitis but not in type I allergic dermatitis.
引用
收藏
页码:77 / 84
页数:8
相关论文
共 49 条
[41]  
Steinhoff M, 1999, EXP DERMATOL, V8, P282
[42]   Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism [J].
Steinhoff, M ;
Vergnolle, N ;
Young, SH ;
Tognetto, M ;
Amadesi, S ;
Ennes, HS ;
Trevisani, M ;
Hollenberg, MD ;
Wallace, JL ;
Caughey, GH ;
Mitchell, SE ;
Williams, LM ;
Geppetti, P ;
Mayer, EA ;
Bunnett, NW .
NATURE MEDICINE, 2000, 6 (02) :151-158
[43]   VUF-K-8788, a periphery-selective histamine H1 antagonist with anti-pruritic activities [J].
Takizawa, T ;
Matsumoto, J ;
Tohma, T ;
Kanke, T ;
Wada, Y ;
Nagao, M ;
Inagaki, N ;
Nagai, H ;
Zhang, MQ ;
Timmerman, H .
JAPANESE JOURNAL OF PHARMACOLOGY, 2001, 86 (01) :55-64
[44]  
TARAYRE JP, 1984, ARCH INT PHARMACOD T, V269, P153
[45]   Inhibition of allergic contact dermatitis to DNCB but not to Oxazolone in interleukin-4-deficient mice [J].
Traidl, C ;
Jugert, F ;
Krieg, T ;
Merk, H ;
Nunzelmann, N .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 112 (04) :476-482
[46]  
Vergnolle N, 1999, J IMMUNOL, V163, P5064
[47]   Characterization of the inflammatory response to proteinase-activated receptor-2 (PAR2)-activating peptides in the rat paw [J].
Vergnolle, N ;
Hollenberg, MD ;
Sharkey, KA ;
Wallace, JL .
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 127 (05) :1083-1090
[48]   Signal transducer and activator of transcription 6 is essential in the induction of contact hypersensitivity [J].
Yokozeki, H ;
Ghoreishi, M ;
Takagawa, S ;
Takayama, K ;
Satoh, T ;
Katayama, I ;
Takeda, K ;
Akira, S ;
Nishioka, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (06) :995-1004
[49]  
ZENGH H, 1995, IMMUNITY, V3, P9